Environmental stewardship and sustainability
(Material Aspect 3)
UCB’s goal is to develop and produce medicines for people with severe diseases in the most environmentally sustainable way possible. To this end, UCB is determined to meet the ambitions set forth in the Paris Agreement reached at the 21st session of the Conference of the Parties (COP21), as demonstrated through the signing of the Science Based Targets Engagement Letter.
Part of UCB’s strategy is to significantly reduce our carbon footprint, our water consumption and our waste production. A stringent and comprehensive action plan to render the operations we control directly carbon neutral by 2030, was endorsed by the Executive Committee in 2016. Absolute targets to reduce GHG emissions by 35% by 2030 and by 70% by 2050, as well as to reduce water consumption by 20% and waste generation by 25% by 2030 were defined.
Our ambition, as well as, our support to the Paris Agreement, were undescored through the signing of the Science Based Targets Engagement Letter by CEO Jean-Christophe Tellier in July 2017.
A stringent and comprehensive action plan to become carbon neutral by 2030, including reduction and compensation mechanisms, has been endorsed by the Executive Committee.